This spontaneous report was received from a pharmacist and concerns an adult female patient of unspecified age 
from the United States, local case ID: 1-1854527884.
The patient's height, weight and medical history were not reported. The patient had previously experienced drug 
allergy when taking codeine and morphine. The patient's drug abuse/illicit drug use, smoking history or alcohol use 
were not reported. The patient was treated with golimumab (liquid, subcutaneous, batch 13E061ME, expiry MAY-
2015) via auto injector, 50 mg initiated on an unspecified date for an unknown indication. Concomitant medications 
included folic acid, tramadol hydrochloride, amitriptyline hydrochloride, levothyroxine sodium, doxycycline hyclate, 
estratest hs, methotrexate, and prednisone. On an unspecified date, when patient took the auotinjector out of the 
box, the button was already depressed. When the cap was taken off, the medicine "poured out". The dose was 
missed as a result. Action taken with golimumab was not reported. The patient outcome was not reported for 
missed dose and product quality issue with the button on a SIMPONI autoinjector. This report was associated with 
Print Time: 14-JAN-2016 03:09 PM If a field is blank, there is no data for that field Page 5 of 12
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
product quality complaint. The complaint vigilance reference number 10000223364 was received.
This report was not serious.